Third SARS-CoV-2 vaccination and breakthrough infections enhance humoral and cellular immunity against variants of concern
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Third SARS-CoV-2 vaccination and breakthrough infections enhance humoral and cellular immunity against variants of concern
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 14, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2023-03-22
DOI
10.3389/fimmu.2023.1120010
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron
- (2022) Alison Tarke et al. CELL
- Comparative analyses of IgG/IgA neutralizing effects induced by three COVID-19 vaccines against variants of concern
- (2022) Eliott Lafon et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant
- (2022) Henning Gruell et al. NATURE MEDICINE
- Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variant
- (2022) Yu Gao et al. NATURE MEDICINE
- Kinetics of the Antibody Response to Boostering With Three Different Vaccines Against SARS-CoV-2
- (2022) Robert Markewitz et al. Frontiers in Immunology
- Analysis of mRNA vaccination-elicited RBD-specific memory B cells reveals strong but incomplete immune escape of the SARS-CoV-2 Omicron variant
- (2022) Aurélien Sokal et al. IMMUNITY
- Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost
- (2022) Frauke Muecksch et al. NATURE
- Broad anti–SARS-CoV-2 antibody immunity induced by heterologous ChAdOx1/mRNA-1273 vaccination
- (2022) Chengzi I. Kaku et al. SCIENCE
- Antibody responses against SARS-CoV-2 variants induced by four different SARS-CoV-2 vaccines in health care workers in the Netherlands: A prospective cohort study
- (2022) Marit J. van Gils et al. PLOS MEDICINE
- SARS-CoV-2-specific T-cell epitope repertoire in convalescent and mRNA-vaccinated individuals
- (2022) Julia Lang-Meli et al. Nature Microbiology
- Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes
- (2022) Jasmin Quandt et al. Science Immunology
- Recall of pre-existing cross-reactive B cell memory following Omicron BA.1 breakthrough infection
- (2022) Chengzi I. Kaku et al. Science Immunology
- Antigenic cartography using sera from sequence-confirmed SARS-CoV-2 variants of concern infections reveals antigenic divergence of Omicron
- (2022) Karlijn van der Straten et al. IMMUNITY
- Lower vaccine-acquired immunity in the elderly population following two-dose BNT162b2 vaccination is alleviated by a third vaccine dose
- (2022) Laurent Renia et al. Nature Communications
- Expansion of cytotoxic tissue-resident CD8+ T cells and CCR6+CD161+ CD4+ T cells in the nasal mucosa following mRNA COVID-19 vaccination
- (2022) Aloysious Ssemaganda et al. Nature Communications
- BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19
- (2022) Georg M. N. Behrens et al. Nature Communications
- Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
- (2021) Merryn Voysey et al. LANCET
- Cellular immunity predominates over humoral immunity after homologous and heterologous mRNA and vector‐based COVID‐19 vaccine regimens in solid organ transplant recipients
- (2021) Tina Schmidt et al. AMERICAN JOURNAL OF TRANSPLANTATION
- BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans
- (2021) Ugur Sahin et al. NATURE
- Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination
- (2021) Joana Barros-Martins et al. NATURE MEDICINE
- SARS-CoV-2 variants, spike mutations and immune escape
- (2021) William T. Harvey et al. NATURE REVIEWS MICROBIOLOGY
- Immune response to SARS-CoV-2 variants of concern in vaccinated individuals
- (2021) Matthias Becker et al. Nature Communications
- SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees
- (2021) Daryl Geers et al. Science Immunology
- The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic
- (2021) Markus Hoffmann et al. CELL
- Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
- (2021) Andrea Cossarizza et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Mechanisms of SARS-CoV-2 entry into cells
- (2021) Cody B. Jackson et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months
- (2021) Einav G. Levin et al. NEW ENGLAND JOURNAL OF MEDICINE
- BNT162b2 vaccination induces durable SARS-CoV-2–specific T cells with a stem cell memory phenotype
- (2021) Gisella Guerrera et al. Science Immunology
- Factors associated with COVID-19-related death using OpenSAFELY
- (2020) Elizabeth J. Williamson et al. NATURE
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
- (2020) Edward E. Walsh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
- (2020) Jordan R. Barrett et al. NATURE MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started